Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.

@article{Reilly1985UltrashortactingBA,
  title={Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.},
  author={Charles S. Reilly and Margaret Wood and R P Koshakji and Alastair J. J. Wood},
  journal={Clinical pharmacology and therapeutics},
  year={1985},
  volume={38 5},
  pages={579-85}
}
Esmolol is a beta 1-selective adrenoceptor blocker that is rapidly metabolized by blood and liver esterases. The beta-receptor and hemodynamic effects of esmolol were determined in a group of 12 healthy men and were compared with those induced by both oral and intravenous propranolol. Esmolol was rapidly effective in inducing at least 90% of steady-state beta-blockade within 5 minutes of either initiating or changing the esmolol infusion rate. More importantly, when esmolol infusion was… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Answering letter to remark of Dr’s Frank and Fitzgerald

European Journal of Clinical Pharmacology • 2017

Similar Papers

Loading similar papers…